GlassScriptPhysician profile
Ravi Goel
NPI 1376576108
$4,329.42
in general payments reported to CMS, 2019-2025
12 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $125 · 2021: $284 · 2022: $79.01 · 2023: $2,598 · 2024: $485 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,438 · Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,437.50 |
| Food and Beverage | $940.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dutch Ophthalmic Research Center (International) B.V. | $2,437.50 | 2023 | Tissueblue, Eva, Combined Machine |
| Johnson & Johnson Surgical Vision, INC. | $439.55 | 2019-2025 | Tecnis Iol, Tecnis Simplicity |
| Biotissue Holdings INC. | $379.01 | 2019-2021 | |
| Alcon Vision LLC | $275.79 | 2019-2024 | Clareon |
| Carl Zeiss Meditec USA, INC. | $255.45 | 2021-2024 | Iolmaster 700, Atlas 500, Quatera 700 |
| Lensar, INC. | $222.69 | 2023-2025 | Lensar Laser System |
| Allergan, INC. | $124.09 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.04 | 2019 | |
| Bausch & Lomb Americas INC. | $69.91 | 2023-2025 | Stellaris, Surgical Misc, Xiidra |
| New World Medical,INC. | $21.06 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sun Pharmaceutical Industries INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.